BRCA1 and cancer: Depletion and inhibition of the activity of CDK1, which phosphorylates BRCA1 and is necessary for the formation of BRCA1 foci and DNA damage repair by HR, was also reported to sensitize cancer but not the untransformed cells to PARP inhibition [38].